NCT06404528招募中不适用
A Clinical Study on the Efficacy and Mechanism of Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours
Wuxi People's Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年9月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Relief degree of tumors
研究概览
简要总结
By controlling the patient's blood sugar, small doses of chemotherapy are used in a hypoglycemic state. Some necrotic tumor cells produced by chemotherapy can maintain their immunogenicity, further activate innate immunity, and produce very strong anticancer effects without the cytotoxic effects of chemotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female aged 18-75 years;
- •ASubjects must have histologically- or cytologically-confirmed diagnosis of advanced solid tumor(s) and have progressed on or is not eligible for available standard therapy;
- •Subjects have at least one measurable lesion according to Response Evaluation Criteria in Solid Tumors (RECIST 1.1) (non-nodal lesions with longest diameter ≥ 10 mm, or nodal lesions with short diameter ≥ 15 mm);
- •ECOG score of 0-2, lifespan > 12 weeks;
- •Women of childbearing age who have a negative pregnancy test within 7 days before treatment. Female patients of childbearing age, and male patients with partners of childbearing age must agree to use at least one medically recognized contraceptive method during study treatment and within at least 6 months after the last dose of investigational drug;
- •Voluntarily participated in this study, signed the informed consent form, had good compliance, and cooperated with the follow-up
排除标准
- •The patient is diagnosed with central nervous system leukemia(symptoms, signs, imaging, cerebrospinal fluid);
- •White blood cell count ≥ 50×10^9/ L or patients with rapid disease progression can't be guaranteed to complete a full treatment cycle;
- •Patients with fungal, bacterial, viral or other uncontrollable infections or requiring four-level isolation treatment.
- •HIV, HBV and HCV positive;
- •Patients with diseases of the central nervous system or autoimmune central nervous system lesions, Including stroke, epilepsy, dementia;
- •Patients have myocardial infection, cardiac angiography or stents, active angina or other obvious clinical symptoms, or have cardiopathic asthma or cardiovascular lymphocytic infiltrates，within 12 months;
- •Patients are on anticoagulation or have severe coagulopathy (APTT>70);
- •Patients in any condition requiring systemic treatment with corticosteroids or other immunosuppressive agents within 2weeks prior to investigational drug administration;
- •Patients were infected with covid-19 within 2weeks prior to investigational drug administration;
- •Subjects having any serious uncontrolled disease or in other conditions that would preclude them from receiving study treatment and are considered unsuitable for this study in the opinion of the investigator;
- •Subjects in other conditions that are considered unsuitable for this study by the investigator.-
结局指标
主要结局
Relief degree of tumors
时间窗: through study completion, an average of 1 year
It will be evaluated by the Response Evaluation Criteria in Solid Tumors（RECIST1.1）
次要结局
- Overall survival（OS）(5 years, year 5)
- Progress free survival（PFS）(3 years, year 3)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2NCT05813912Novo Nordisk A/S148
已完成
1 期
Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During HypoglycaemiaDiabetesDiabetes Mellitus, Type 1NCT00760448Novo Nordisk A/S25
Unknown
不适用
The Management of Glucose Control and Hypoglycemic Prevention Using Continuous Glucose Monitoring System in Patients With Type 1 DiabetesType 1 DiabetesNCT04684030Yonsei University60
已完成
Unknown
A study on changes in glycemic control in patients with type 2 diabetes using food delivery serviceType 2 diabetesJPRN-UMIN000049094Respiratory Medicine, Miyazaki RC Clinic14
已完成
不适用
Effect of Low Glycemic Index on Gestational Diabetes MellitusGestational Diabetes MellitusNCT03801824Universiti Putra Malaysia40